The simple suspension method (SSM) is a method of administering drugs via feeding or gastrostomy tubes to those who have difficulty swallowing. In the SSM, solid formulations (eg, tablets, capsules) are immersed in hot (55℃) water. This promotes the disintegration and dissolution of the drugs and changes their solubility. However, pharmaceutical companies have not issued test results on the solubility and dissolution behaviors of suspended drugs prepared according to the SSM. For this study, we chose 10 drugs, 8 listed and 2 not listed in the Japanese Orange Book, to compare the dissolution behaviors of each drug, treated vs untreated with the SSM. Dissolution was classified into three patterns: rapid (gliclazide and famotidine), moderate (propranolol, pindolol, metoprolol), and slow (furosemide, ibuprofen, glimepiride). The initial dissolution rates of the moderate-dissolution drugs increased markedly by employing the SSM. In this study, hydroxyzine capsules and phenytoin tablets, neither of which is listed in the Japanese Orange Book, were compared with different dosage/administration forms of those drugs listed in the book (ie hydroxyzine tablets and phenytoinphenobarbital combination tablets).
Introduction
In today＇s medical practice, oral solid formulations (tablets and capsules) are excellent in portability and ingestibility. However, such formula- The employability of the SSM and the stability of SSM-administered drugs have been discussed in many studies. Yano et al 6) compared proprietary and generic pravastatin products, while
Miyamoto et al 7) compared amantadine and 5 other
proprietary and generic products, to point out that treatment of the SSM resulted in a significant difference in tube permeability between some of proprietary and generic products. Yano et al 8) confirmed that 8 types of suspended drugs, including phenytoin and digoxin, were found to be stable. Suryani et al 9) demonstrated that suspended ester prodrugs (acemetacin, cefpodoxime proxetil)
are stable individually, although their ester bond is cut when they are mixed with magnesium oxide.
Pharmaceutical companies are obliged to test developed formulations prior to their distribution on the market. However, the tests do not cover the administration of drug suspensions in hot (55℃)
water. Accordingly, there are no data accessible or reported on the dissolution behavior of suspended formulations in the SSM.
In previous studies, we examined the solubility of poorly water-soluble tablets (phenytoin and ibuprofen) in the SSM. 10) We found that the SSM promotes the immediate dissolution of phenytoin to the saturated concentration, whereas it promotes the gentle dissolution of ibuprofen. This might suggest that drugs which dissolve immediately when suspended may have enhanced solubility for the major ingredients in the drugs, and thus, the absorbability of the drug by the digestive canal may be affected. However, no details have been con rmed. This necessitates further studies on the passability of suspended drugs through gastrostomy tubes as well as on the solubility of those drugs, which will thus be used to determine whether the SSM can be used for the administration of each drug.
Studies on the applicability of the SSM to commercially available individual oral formulations require a lot of time; thus they are impractical.
The Japanese Orange Book lists dissolution test data for 688 pharmaceutical ingredients that are orally administered (as of January 10, 2015) .
However these data are the dissolution pro le of the intact drug (untreated with the SSM), thus it is not possible to apply the estimation for drugs treated with the SSM directly. In this study, we focused on the data in the Japanese Orange Book and on interview forms, both of which report dissolution pro les of oral formulations, for the purpose of comparing treated vs untreated drugs with the SSM in terms of dissolution behavior.
Moreover, the data does not cover some ingredients, such as hydroxyzine pamoate and phenytoin. Hydroxyzine pamoate is only listed for tablets and not capsules, and phenytoin tablets are included as a combined drug with phenobarbital, but are not listed independently. We also discuss the validity of the data on one form of ingredient with respect to a different form. 
Materials & Methods

Reagent
Information gathering by Japanese Orange Book
The Japanese Orange Book provides online the pro les of drug dissolution behavior (http://www. 
Simple suspension method (SSM)
The simple suspension method, employed in accordance with the procedure suggested by 
Dissolution test
In accordance with the Japanese Pharmacopoeia 16th Edition (JP), we performed dissolution tests of the drugs by employing the paddle method (DT600, Erweka GmbH, Heusenstamm, Germany).
Each drug was subject to comparison between treated and untreated (the control). 900 mL of 1st uid (pH 1.2, speci ed for the JP dissolution test)
was used for the test, and the temperature of the uid was kept at 37 ± 0.5℃. The paddle rotation 
HPLC analysis conditions
Analysis was made by using the Shimadzu 
Statistical analysis
All data were presented as the mean value ± standard deviation (SD). The difference in solubility of treated vs untreated drugs with the SSM was evaluated by Student＇s t-test, and signi cance was de ned as P < 0.05.
Results
Dissolution behavior of drugs listed in
Japanese Orange Book According to Table 2 , more than 80％ of gliclazide and the famotidine dissolved within 10 min, less than 50％ of the propranolol, the pindolol and the metoprolol dissolved within 10 min, and most of them dissolved in 60 min. Furosemide, ibuprofen and glimepiride dissolved very slowly, with less than 50％ dissolution in 60 min.
From the data, the drugs tested for this study 
Change in dissolution behavior of SSMtreated drugs
Next, we analyzed the dissolution behaviors of treated vs untreated drugs with the SSM for the rapid-dissolution group, the moderate-dissolution group and the slow-dissolution group. In the rapid-dissolution group, treated gliclazide was found to have a slightly greater solubility than untreated gliclazide (Fig 1A) . Treated famotidine was found to have double the solubility of untreated famotidine at 5 min, the behavior became similar between the two in 10 min (Fig 1B) .
In the moderate-dissolution group, treated propranolol dissolved rapidly for the first 15 min, which showed a significant difference from untreated propranolol (Fig 2A) . Treated pindolol also dissolved rapidly. A significant difference was recognized between treated and untreated pindolol in the rst 5 min, and that difference remained the same at 45 min (Fig 2B) . In addition, metoprolol showed a great difference in solubility within 15 min, although most of the drug dissolved in 30 min whether or not it was treated with the SSM (Fig 2C) .
In the slow-dissolution group, less than 20％ of treated furosemide dissolved within 5 min, which was still more than double that for untreated furosemide (Fig 3A) . Whether or not it was treated with the SSM, furosemide continued to dissolve at a constant rate, and the difference in solubility between treated and untreated drugs remained approximately 10％. The solubility of treated ibuprofen was approximately 3 percentage points greater than untreated ibuprofen in 10 min, and the difference remained the same subsequently (Fig 3B) . The solubility of glimepiride was approximately 2 percentage points different for treated vs untreated at 5 min, the difference narrowing eventually to nil at 30 min (Fig 3C) .
Data of formulations unlisted in Japanese Orange Book
In the dissolution pro le of untreated hydroxyzine pamoate capsule (Fig 4A) , less than 40％ of the hydroxyzine dissolved in 10 min and most of them dissolved in 60 min. Therefore this drug be- (Fig 4A, dashed line) .
Given the same conditions, the dissolution behavior of hydroxyzine pamoate capsule (25 mg) was found to signi cantly differ from that of hydroxyzine pamoate tablet: The capsule dissolved faster than the tablet.
In the dissolution pro le of untreated phenytoin tablet (Fig 4B) , less than 15％ of phenytoin dissolved in 10 min, and it was almost saturated in the solution at 30 min. This result suggests that the phenytoin tablet belongs to the slow-dissolution group. Treated phenytoin tablet was rapidly dissolved within 5 min, but the difference of solubility between treated and untreated with the SSM was reduced same as the dissolution profile of glimepiride (Fig 3C) . On the other hand, a combined tablet of phenytoin (67 mg) and phenobarbital (33 mg) dissolved faster than a single tablet of phenytoin (100 mg) : the combination tablet dissolved more than 80％ at 60 min (Fig 4B, dashed line), the single tablet dissolved only 25％ (Fig 4B, solid line) .
Discussion
In previous studies, we examined the solubility of poorly water-soluble drugs that were treated with the SSM, and we reported that phenytoin and pranlukast 10) dissolved in the suspension to the saturated solubility. This suggests that the SSM (Fig 2B) . The difference of dissolution behavior between treated and untreated drugs was greater for pindolol than for propranolol and metoprolol, probably because of the dissolution profile of the untreated drug:
Only 67％ of untreated pindolol dissolved in 30 min ( Table 2 ). form is considered to almost completely dissolve via the SSM, similarly to gliclazide (Fig 1A) .
Using the SSM to suspend drugs omits the pro- 
